REVION+

T I R Z E P A T I D E

A long-acting dual GIP and GLP-1 receptor agonist designed to support metabolic regulation, appetite control and weight management.

Pharmaceutical Grade · United States
120 mg Per Vial
3 ml Sterile Solution
5 doses Per Vial
Once Weekly

Dual Receptor Agonist

GIP & GLP-1
Receptor Agonist

REVION+ Tirzepatide is a solution for subcutaneous injection supplied in a multi-dose vial. Each vial contains 120 mg Tirzepatide in 3 ml of sterile solution, providing 5 full doses of 0.6 ml — each delivering 24 mg.

As a dual agonist of both GIP and GLP-1 receptors, tirzepatide works synergistically to support metabolic regulation, appetite control and weight management.

RVN-TIR120-VIAL Product Code
United States Origin
Composition 120 mg Tirzepatide
Volume 3 ml sterile solution
Doses per vial 5 × 0.6 ml
Per dose (max) 24 mg Tirzepatide
Route Subcutaneous injection
Frequency Once weekly

Dosing Reference

Dosing Guide

Draw the correct dose into the syringe according to the table below. Do not exceed 60 units (24 mg) within any 7-day period.

7 units
2.5 mg Tirzepatide
13 units
5 mg Tirzepatide
19 units
7.5 mg Tirzepatide
25 units
10 mg Tirzepatide
32 units
12.5 mg Tirzepatide
38 units
15 mg Tirzepatide
45 units
18 mg Tirzepatide
50 units
20 mg Tirzepatide
60 units
24 mg Maximum dose

Step-Up Protocol

Recommended
Dosing Protocol

Administered once weekly. Start with a lower dose to minimise gastrointestinal side effects.

Weeks 1–4
2.5 mg 7 units / week
Initial phase
Weeks 5–8
5 mg 13 units / week
Dose escalation phase
Weeks 9–12
7.5 mg 19 units / week
Intermediate phase
Standard
10 mg 25 units / week
Standard therapeutic dose
Higher
15 mg 38 units / week
Higher therapeutic dose (if required)
Maximum
24 mg 60 units / week
Maximum recommended dose

Instructions for Use

Before Each
Injection

Vial label reads REVION+ TIRZEPATIDE
Solution is clear and colourless
Product is within its expiry date
Use a new needle for every injection

Do not use if the solution appears cloudy, discoloured, or contains visible particles. Never use a bent or damaged needle. Dispose of used needles in an approved sharps container.

Injection sites: Abdomen (≥5 cm from navel), upper outer thigh, or upper arm. Rotate sites weekly.

Storage

Before first use 2 °C – 8 °C (refrigerated)
After first use Store below 25 °C
Discard after 28 days from first use
Protection Protect from direct sunlight. Do not freeze.

Package Insert

Complete Package Leaflet

REVION+ TIRZEPATIDE — Solution for Injection in Multi-dose Vial
IFU Code: RVN-TIR120-EN-V1.0  –  Revision Date: 2026

Your browser does not support inline PDF viewing.

Leaflet-Tirpezatide Revion FINAL 120mg.pdf